Genome Research Gateway 2 Ultimate ORF

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Genome Res. 14:2076-2082, 2004
©2004 by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/04 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Research Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aguiar, J. C.
Right arrow Articles by Carucci, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aguiar, J. C.
Right arrow Articles by Carucci, D. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Letter

High-Throughput Generation of P. falciparum Functional Molecules by Recombinational Cloning

João Carlos Aguiar1,3,8, Joshua LaBaer2, Peter L. Blair1, Victoria Y. Shamailova1, Malvika Koundinya2, Joshua A. Russell1, Fengying Huang1, Wenhong Mar2, Robert M. Anthony1,4, Adam Witney1,5, Sonia R. Caruana1, Leonardo Brizuela2, John B. Sacci, Jr.1,6, Stephen L. Hoffman1,7 and Daniel J. Carucci1

1 Malaria Program, Naval Medical Research Center, Silver Spring, Maryland 20910, USA 2 Harvard Institute of Proteomics, Cambridge, Massachusetts 02141, USA 3 Pan American Health Organization, Washington, DC 20037, USA

Large-scale functional genomics studies for malaria vaccine and drug development will depend on the generation of molecular tools to study protein expression. We examined the feasibility of a high-throughput cloning approach using the Gateway system to create a large set of expression clones encoding Plasmodium falciparum single-exon genes. Master clones and their ORFs were transferred en masse to multiple expression vectors. Target genes (n = 303) were selected using specific sets of criteria, including stage expression and secondary structure. Upon screening four colonies per capture reaction, we achieved 84% cloning efficiency. The genes were subcloned in parallel into three expression vectors: a DNA vaccine vector and two protein expression vectors. These transfers yielded a 100% success rate without any observed recombination based on single colony screening. The functional expression of 95 genes was evaluated in mice with DNA vaccine constructs to generate antibody against various stages of the parasite. From these, 19 induced antibody titers against the erythrocytic stages and three against sporozoite stages. We have overcome the potential limitation of producing large P. falciparum clone sets in multiple expression vectors. This approach represents a powerful technique for the production of molecular reagents for genome-wide functional analysis of the P. falciparum genome and will provide for a resource for the malaria resource community distributed through public repositories.


8 Corresponding author.
E-MAIL aguiarj{at}nmrc.navy.mil; FAX (301) 319-7545.

4 Present address: Microbiology and Immunology, Uniformed Services University, Bethesda, MD 20814, USA

5 Present address: Department of Cellular and Molecular Medicine, St. George's Hospital Medical School, London SW17 0RE, UK

6 Present address: Department of Microbiology and Immunology, The University of Maryland School of Medicine, Baltimore, MD 21201, USA

7 Present address: Sanaria Inc., Rockville, MD 20852, USA.

[Supplemental material is available online at www.genome.org. All entry clones from both Panels A and B have been deposited at the Malaria Research and Reference Reagent Resource Center (http://www.malaria.mr4.org) for distribution to researchers upon request. The following individuals kindly provided reagents, samples, or unpublished information as indicated in the paper: Y. Charoenvit and P. de la Vega.]

Article and publication are at http://www.genome.org/cgi/doi/10.1101/gr.2416604.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Infect. Immun.Home page
T. Tsuboi, S. Takeo, H. Iriko, L. Jin, M. Tsuchimochi, S. Matsuda, E.-T. Han, H. Otsuki, O. Kaneko, J. Sattabongkot, et al.
Wheat Germ Cell-Free System-Based Production of Malaria Proteins for Discovery of Novel Vaccine Candidates
Infect. Immun., April 1, 2008; 76(4): 1702 - 1708.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
D. Haddad, J. Maciel, and N. Kumar
Infection with Plasmodium berghei Boosts Antibody Responses Primed by a DNA Vaccine Encoding Gametocyte Antigen Pbs48/45
Infect. Immun., April 1, 2006; 74(4): 2043 - 2051.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Genes Dev. Learn. Mem.
Protein Science RNA Genome Res.
Copyright © 2004 by Cold Spring Harbor Laboratory Press.